2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow group 4: new trials by email Literature Review of group 4 trials Research Report on group 4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD) Part 1, Part 2 Group 1, Part 2 group 2 - Anaphylaxis | Phase 1 | Completed | Bausch & Lomb Incorporated | 43 | 2017-03-23 | 2019-06-21 |
| Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients group 1, group 2, group 3 - Melanoma | Phase 1 | Completed | Centre Hospitalier Universitaire Vaudois | 29 | 2003-04-01 | 2013-04-22 |
Anaphylaxis (1) · Melanoma (1)
Bausch & Lomb Incorporated (1) · Centre Hospitalier Universitaire Vaudois (1)
Germany (1) · Switzerland (1)
Beate Klaus, MD (1) · Olivier Michielin, MD (1)